Other
Vifor Pharma
is a Switzerland-based pharmaceutical company that develops nephrology and cardio-renal therapies for the treatment of heart failure and kidney diseases... Read moreVifor Pharma
is a Switzerland-based pharmaceutical company that develops nephrology and cardio-renal therapies for the treatment of heart failure and kidney diseases... Read moreNews
Dec 12, 2024
The Pharmaceutical Journal
Vifor Pharma: Manufacturer offers NHS 23m in response to investigation into misleading claims about rival treatment
Jul 22, 2024
STAT News
Vifor Pharma: STAT+: European Commission reaches deal with Vifor for 'disparaging' its only rival in iron deficiency market
Jul 22, 2024
Yahoo
Vifor Pharma: EU antitrust regulators accept Vifor Pharma's pledge not to disparage rival
Jun 18, 2024
Pharamceutical Technology
Vifor Pharma: Ferric carboxymaltose by Vifor Pharma Management for Restless Legs Syndrome: Likelihood of Approval
Apr 19, 2024
PharmaLive
Vifor Pharma: Vifor Pharma offers to rectify anti-competitive behavior against rival
Mar 20, 2024
Medthority
Vifor Pharma: Ferinject (ferric carboxymaltose) approved by Health Canada for the treatment of iron deficiency anemia in adult and pediatric patients and iron deficiency in adult patients with heart failure
Feb 23, 2024
Saltwire
Vifor Pharma: Travere drug for rare kidney condition recommended for EU approval | SaltWire
Jan 31, 2024
MarketScreener
Vifor Pharma: UK regulator probes Vifor Pharma for anti-competitive behaviour
May 19, 2023
Pharmaceutical Business Review
Vifor Pharma: NICE recommends Cara's Kapruvia to treat CKD-associated pruritus
May 02, 2023
FinanzNachrichten
Vifor Pharma: Vifor International AG (CSL Vifor): Topline Results from Two-Year Primary Efficacy Endpoint in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis
Vifor Pharma Competitors
1
2
3
4
5
6
7
8
9
10